Trial Profile
Phase I study on tolerability of AVN 211 for treatment of schizophrenia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jun 2013
Price :
$35
*
At a glance
- Drugs AVN 211 (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Avineuro Pharmaceuticals
- 01 Apr 2009 New trial record.